Patent ID: 6930207

Claim:
A method of treating or inhibiting obesity, metabolic syndrome hypotension, insulin resistance, dyslipoproteinaemia or hyperuricaemia in a mammal, said method comprising administering to said mammal an effective amount of a compound corresponding to formula I, wherein A 1 is a group of the formula R 1 —W—A 3 —Y—(CH 2 ) n —, wherein R 1 is hydrogen, lower alkyl, C 3-7 -cycloalkyl, phenyl-C 0-4 -alkyl or naphthyl; W is a bond or oxygen; A 3 is a bond or C 1-20 -alkylene; Y is a bond or oxygen and n is a whole number from 0 to 3; R 2 is hydrogen, lower alkyl, lower alkoxy or halogen, or A 1 and R 2 , together with the carbon atoms to which they are bonded, form a C 5-7 -cycloalkyl group; Z is a bond, oxygen or carbonyl and A 2 is C 1-20 -alkylene.